This study evaluated heterogeneity in the HCV NS3 protease sequences isolated from HCV from a group of Brazilian patients with chronic hepatitis C whose responses to PEG-IFN and RBV treatment (SVR, REL and NR) were being monitored. The gene discussed is KRAS; the disease is chronic hepatitis C virus infection.